# OLANZAPINE
> **ANDA202889** · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2023-03-09
## Drug
- **FDA Application Number:** ANDA202889
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OLANZAPINE
- **Generic name:** Olanzapine
- **Active ingredients:** OLANZAPINE
- **Dosage form:** TABLET, ORALLY DISINTEGRATING
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ZYDUS PHARMS
- **First approval:** 2023-03-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202889)
---
*AI Analytics · CC0 1.0*